touchINFECTIOUS DISEASES touchINFECTIOUS DISEASES
Start activity

Tutorial

These icons indicate there is something to be interacted with. Click it when you see it.

Poll

How confident are you in testing for and managing ART resistance?

Submit your answer to see the results

Not confident
   
A little confident
   
Moderately confident
   
Very confident
   

Tutorial

These icons indicate there is something to be interacted with. Click it when you see it.

Poll

In the absence of specific contraindications, which initial ART regimen do you normally recommend?

Submit your answer to see the results

Three-drug: Two NRTIs + one INSTI
   
Two-drug: One NRTI + one INSTI
   
Three-drug: Two NRTIs + one NNRTI
   
Three-drug: Two NRTIs + one boosted PI
   

Tutorial

These icons indicate there is something to be interacted with. Click it when you see it.

Poll

How confident are you in describing the virology and life cycle of HIV?

Submit your answer to see the results

Not confident
   
A little confident
   
Moderately confident
   
Very confident
   
 
Expert Interviews

touchEXPERT OPINIONS
Experts answer questions with in-depth advice on the current clinical landscape and how new therapies and guidance might impact regional clinical practice. Useful tips below will show how to navigate the activity. Close

Demystifying virology: The link between the HIV life cycle and ART

Take CE/CME Test

Anne-Mieke Vandamme is a full professor in the medical faculty at the Katholieke Universiteit (KU) Leuven, in Belgium, where she also teaches evolutionary genetics and bioinformatics. She is the head of the Institute of the Future, a transdisciplinary research incubator at KU. read more

Prof. Vandamme and her team research the molecular epidemiology of HIV, HTLV, HCV and arboviruses; HIV and HCV drug resistance testing in clinical context; and bioinformatic tools. She has extensive and widely recognized expertise in molecular epidemiology and drug resistance. She has been participating in several European projects (currently ZIKAlliance and STEAM+), and supported the development of widely used bioinformatic tools: the Rega HIV drug resistance algorithm, the Rega HIV typing and subtyping tool and RegaDB. At the Institute of the Future, she coaches teams that incubate transdisciplinary research projects geared towards the United Nations Sustainable Development Goals.

She has authored more than 400 publications in international journals such as Lancet, Nature Medicine, Lancet Infectious Diseases, PNAS, Journal of Virology and Trends in Microbiology.

Prof. Anne-Mieke Vandamme has no interests/relationships or affiliations to disclose in relation to this activity.

Take CE/CME Test
Learning Objectives
  • Outline the virology of the HIV life cycle and how it is targeted by different antiretroviral therapies
  • Summarize the mechanism of action of current available antiretroviral therapies and the rationale for combining them
  • Discuss the risk of resistance to currently available antiretrovirals and strategies to monitor and manage resistance
Overview

In this activity, three HIV experts share their insights on the virology of HIV, the rationale for multidrug antiretroviral therapy (ART) regimens, the mechanisms by which ART resistance develops and how to manage it in people living with HIV.

This activity is provided by touchIME.

Target Audience

This activity has been designed to meet the educational needs of primary care physicians, HIV specialists, infectious disease specialists, genitourinary medicine specialists, specialist nurse practitioners and virologists involved in the management of HIV.

Faculty

Prof. Anne-Mieke Vandamme has no interests/relationships or affiliations to disclose in relation to this activity.

Prof. José Arribas discloses:  Advisory board or panel fees from Gilead Sciences, Janssen, MSD and ViiV Healthcare. Consultancy fees from AbbVie, Gilead Sciences, Janssen, MSD and ViiV Healthcare. Grants/research support from ViiV Healthcare.

Prof. Antonella Castagna discloses: Advisory board or panel fees from Gilead Sciences, Janssen-Cilag and MSD. Grants/research support from ViiV Healthcare.

Touch Medical Contributors

Adriano Boasso has no financial interests/relationships or affiliations in relation to this activity.

Date of original release: 31 July 2024

  • Select in the video player controls bar to choose subtitle language. Subtitles available in English, French, German, Spanish.
  • Downloads including slides are available for this activity in the Toolkit

Topics covered in this activity

HIV / Sexually Transmitted Infections / Viral Infections
REGISTER NOW FOR FREE ACCESS TO
  • 1000+ topical and insightful peer-reviewed journal articles
  • 100+ hours of bite-sized congress highlights
  • 10 major therapy areas packed with the latest scientific advances
  • 150+ specialties offering learn-on-the-go medical education
  • + Concise email updates and newsletters so you never miss out
Register For Free Now

Journal articles and more to your inbox


Get the latest clinical insights from touchINFECTIOUS DISEASES

Sign me up!
Claim Credit
touchEXPERT OPINIONS
Demystifying virology: The link between the HIV life cycle and ART

Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
Close Popup